Skip to main content
Morepen Laboratories Ltd. logo

Morepen Laboratories Ltd. — Investor Relations & Filings

Ticker · MOREPENLAB ISIN · INE083A01026 LEI · 335800OJZDFHFQJ4HP35 BSE.NS Manufacturing
Open in API
Filings indexed 1,660 across all filing types
Latest filing 2023-05-29 Regulatory Filings
Country IN India
Listing BSE.NS MOREPENLAB

About Morepen Laboratories Ltd.

https://www.morepen.com

Morepen Laboratories Ltd. is a research-led company specializing in the development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), home diagnostic devices, and finished formulations. The company maintains a significant global presence, exporting high-quality APIs such as Loratadine, Montelukast, Atorvastatin, and Fexofenadine to numerous international markets. Its diagnostic division, branded as Dr. Morepen, is a prominent player in the home healthcare segment, offering a wide range of products including digital glucometers, blood pressure monitors, and nebulizers. Morepen operates manufacturing facilities compliant with international regulatory standards, including USFDA approvals. The company focuses on leveraging its R&D capabilities to deliver healthcare solutions and maintains a diverse portfolio across various therapeutic areas including cardiovascular, anti-diabetic, and anti-asthmatic treatments.

Recent filings

Filing Released Lang Actions
Pursuant to the Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find attached herewith ....
Regulatory Filings
2023-05-29 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the loss of a share certificate and the issuance of a duplicate certificate. It references regulatory compliance under SEBI regulations and includes details about the shareholder and share certificate. The document is an official notification about a specific event related to share certificates, not a financial report, earnings release, or management discussion. It does not contain financial data or results, nor is it a report or presentation. It is a regulatory announcement related to shareholding documentation. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-05-24 English
Pursuant to the Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find attached herewith ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (NSE and BSE) regarding the loss of a share certificate by a shareholder and the request for issuance of duplicate share certificates. It references compliance with SEBI regulations and circulars related to share certificate loss. The content is about notifying the exchange of a shareholder's lost share certificate and the procedural follow-up, not about financial results, management changes, or capital structure changes. It is a regulatory announcement related to shareholding but does not indicate a change in major shareholding levels or insider transactions. It is not a report, earnings release, or management information. The document is best classified as a Regulatory Filing (RNS) because it is a compliance-related notification to the stock exchange that does not fit other specific categories.
2023-05-24 English
Annual Secretarial Compliance Report
Regulatory Filings Classification · 95% confidence The document is titled 'Annual Secretarial Compliance Report for the financial year ended 31st March 2023' and is issued by a practicing company secretary. It details compliance with SEBI regulations and other statutory requirements for the financial year ended 31 March 2023. The content includes examination of filings, policies, disclosures, auditor resignations, and compliance status. It is a compliance certification report rather than a full financial report or audit report. It does not contain financial statements or detailed financial analysis. The document is a regulatory compliance report related to secretarial standards and SEBI regulations, which fits best under Regulatory Filings (RNS) as it is a statutory compliance report and not an annual report, audit report, or other specific financial filing.
2023-05-23 English
Pursuant to Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Annual Secretarial Compliance Report of Morepen ....
Regulatory Filings Classification · 95% confidence The document is titled 'Annual Secretarial Compliance Report for the financial year ended 31st March 2023' and is issued by a practicing company secretary. It details compliance with SEBI regulations, listing obligations, and other corporate governance requirements for the financial year ended March 31, 2023. The content includes examination of filings, policies, disclosures, auditor resignations, and compliance status. It is a compliance certification report rather than a full financial report or audit report. It is not an Annual Report (10-K), Audit Report (AR), or Interim Report (IR). It is a specialized compliance report related to secretarial and regulatory adherence. This type of document is best classified under Regulatory Filings (RNS) as it is a regulatory compliance report and does not fit other specific categories like Annual Report or Audit Report. The document length (15,000 characters) and detailed compliance content support this classification with high confidence.
2023-05-23 English
Loss of Share Certificates
Regulatory Filings
2023-05-18 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.